يعرض 1 - 10 نتائج من 69 نتيجة بحث عن '"T. Ouassa"', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

  7. 7

    المساهمون: Laboratoire de génie des procédés - environnement - agroalimentaire (GEPEA), Mines Nantes (Mines Nantes)-Université de Nantes - UFR des Sciences et des Techniques (UN UFR ST), Université de Nantes (UN)-Université de Nantes (UN)-Ecole Nationale Vétérinaire, Agroalimentaire et de l'alimentation Nantes-Atlantique (ONIRIS)-Centre National de la Recherche Scientifique (CNRS), International Foundation for Science, Sweden [E/4955-1]

    المصدر: Food Control
    Food Control, Elsevier, 2016, 62, pp.397-404. ⟨10.1016/j.foodcont.2015.09.037⟩

  8. 8

    المساهمون: Maternité Port-Royal [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de Recherche pour le Développement (IRD), Institut de Recherche en Sciences de la Santé (IRSS) / Centre Muraz, Epidémiologie, santé publique et développement, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Programme PAC-CI, ANRS France Recherche Nord & sud Sida-hiv hépatites, Institut Pasteur de Côte d'Ivoire, Réseau International des Instituts Pasteur (RIIP), Departement de Gynécologie Obstétrique, CHU de Youpougon, The ANRS 049/Ditrame project was funded by the French Agence Nationale de Recherches sur le SIDA (ANRS) and the French Ministry of Cooperation (Action Coordonnée no 12)., The authors wish to thank the nurses and counsellors working with the Ditrame project and the staff from the participating prenatal care and delivery unit for their daily compassionate work. Special thanks to Drs MA Nandeuil, M Mathieu, and C Meignant (Innothéra, France) for assisting in the preparation of the trial, especially drug supply, packaging, and shipping.

    المصدر: Sexually Transmitted Infections
    Sexually Transmitted Infections, BMJ Publishing Group, 2002, 78 (4), pp.267-270. ⟨10.1136/sti.78.4.267⟩

    مصطلحات موضوعية: Pediatrics, TRANSMISSION MERE ENFANT, ESSAI CLINIQUE, Placebo-controlled study, HIV Infections, NAISSANCE, MESH: Proportional Hazards Models, MESH: Pregnancy, 0302 clinical medicine, Pregnancy, Risk Factors, GROSSESSE, MESH: Risk Factors, Infant Mortality, INFECTION, MESH: Administration, Intravaginal, Childbirth, MESH: Double-Blind Method, MESH: Infant Mortality, 030212 general & internal medicine, Pregnancy Complications, Infectious, reproductive and urinary physiology, ANALYSE STATISTIQUE, MESH: Treatment Outcome, education.field_of_study, integumentary system, SIDA, Obstetrics, virus diseases, Prenatal Care, MESH: HIV Infections, MESH: Follow-Up Studies, MESH: Infant, female genital diseases and pregnancy complications, 3. Good health, MESH: Infectious Disease Transmission, Vertical, Perinatal Care, Treatment Outcome, Infectious Diseases, MESH: Survival Analysis, MESH: Perinatal Care, Female, Original Article, Benzalkonium Compounds, HYGIENE, MESH: Benzalkonium Compounds, Maternal Age, Adult, medicine.medical_specialty, TRANSMISSION, MESH: Cote d'Ivoire, Population, Dermatology, Prenatal care, Placebo, MESH: Multivariate Analysis, 03 medical and health sciences, MESH: Anti-Infective Agents, Local, Double-Blind Method, 030225 pediatrics, Burkina Faso, medicine, Humans, MESH: Pregnancy Complications, Infectious, MESH: Burkina Faso, education, MESH: Prenatal Care, MESH: Suppositories, Proportional Hazards Models, MESH: Humans, Intention-to-treat analysis, business.industry, Suppositories, Infant, MESH: Adult, Delivery, Obstetric, medicine.disease, Survival Analysis, [SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology, Infectious Disease Transmission, Vertical, Infant mortality, body regions, Administration, Intravaginal, ACCOUCHEMENT, Cote d'Ivoire, Multivariate Analysis, Anti-Infective Agents, Local, MESH: Delivery, Obstetric, MESH: Maternal Age, MORTALITE INFANTILE, business, MESH: Female, Follow-Up Studies

  9. 9
  10. 10